Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantBEIGENE SINGAPORE PTE. LTD.
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification
Formulation Information
INFUSION, SOLUTION CONCENTRATE
INTRAVENOUS
Medical Information
L01FF09
Manufacturer Information
BEIGENE SINGAPORE PTE. LTD.
Boehringer Ingelheim Biopharmaceuticals (China) Ltd
Active Ingredients
Documents
Package Inserts
Tevimbra PI.pdf
Approved: September 19, 2024